To investigate the mechanisms underlying the cerebroprotective effects of combination treatment with J147 and tPA, we first explored whether the combination therapy reduced ischemia-induced neuroinflammation and delayed tPA-associated hemorrhagic transformation. Here, PLAT is linked to ischemia.